As of August 28, 2026, Curanex Pharmaceuticals Inc (CURX) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. Curanex Pharmaceuticals Inc has a market capitalization of $9.43M, 31.36M shares outstanding, 9 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.41 below $1 exchange minimum
• Only 3 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 3 months remaining
Market Data
Market Cap$9.43M
Shares Outstanding31.36M
Float8.91M
Cash$2.94M
Debt$476.5K
Short InterestN/A
Institutional Holdings
QoQ: ↓ 21.8% shares (2026Q1 vs prior)
9 institutional holders · 332.4K shares
#1
GEODE CAPITAL MANAGEMENT, LLC
111.1K shares
#2
TWO SIGMA SECURITIES, LLC
56.7K shares
#3
XTX Topco Ltd
51.3K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest12.4K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CURX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CURX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CURX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.